Alkermes Plc

Common Name
Alkermes
Country
Ireland
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,800
Ticker
ALKS
Exchange
NASDAQ/NGS
Description
Alkermes plc is a prominent biopharmaceutical company focusing on the development and commercialization of innovative medicines aimed at addressing unmet medical needs in major therapeutic areas such ...

Disclosures of Alkermes

Explore Alkermes's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Alkermes's official channels and fully traceable to its official company sources.

The table below lists all of Alkermes's' corporate disclosure by name and reporting period, ensuring full transparency and easy access. Coming soon, Tracenable users will be able to export disclosures as PDFs, view them in Markdown, or open them directly in ChatGPT or Claude for instant analysis and summarization.

NameReporting Period
Corporate Responsibility Report (CRR)2024
Financial Report2024
Financial & Extra-Financial Disclosure2024
Financial & Extra-Financial Disclosure2023
Corporate Responsibility Report (CRR)2023
Financial Report2023
10-K2023
10-K2022
Financial Report2022
Corporate Responsibility Report (CRR)2022
10-K2021
Corporate Responsibility Report (CRR)2021
Financial Report2021
10-K2020
Financial Report2020
Corporate Responsibility Report (CRR)2020
10-K2019
Corporate Responsibility Report (CRR)2019
Financial Report2019
10-K2018
Financial Report2018
Corporate Responsibility Report (CRR)2018
10-K2017
Financial Report2017
10-K2016
Financial Report2016
10-K2015
Financial Report2015
10-K2014
Financial Report2014
10-K2013
Financial Report2013
10-K2012
Financial Report2012
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?